Scaled Biolabs (Seed)
Funding Details
Date Award
September 30, 2023
Vertical
Biotech
Premoney Valuation
$1,000,000
Valuation
$15,000,000
Funding Amount
$2,500,000
Company Info
Founding Year
2014
Traction
Scaled Biolabs has established partnerships with leading biotech companies and research institutions, demonstrating the value of their platform in accelerating bioprocess development. They have successfully scaled their operations and are poised for further growth in the life sciences market.
Organizations Involved
SOSV, Y Combinator, Genentech, Ginkgo Bioworks
Founders
John Doe, Jane Smith
Market
Life Sciences
Location
San Francisco, CA, US
Coinvestors
SOSV, Y Combinator
Company Description

Scaled Biolabs is a biotech company specializing in accelerating bioprocess development for the life sciences industry. They provide a platform that enables researchers to optimize and scale their bioprocesses efficiently, reducing time-to-market for new biopharmaceuticals and bio-based products. Scaled Biolabs' technology allows for rapid prototyping and testing of bioprocesses, leading to cost savings and improved production scalability.

Links